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Abstract  
Rheumatic fever (RF) may often be encountered in 
developing country including in Indonesia. RF is 
autoimmune disease resulted from Group-A 
Streptococcus upper respiratory tract infection. RF 
diagnostic criteria underwent some changes since it 
was first arranged. Patients with RF episode history have 
a higher risk to experience recurrence following Group-A 
Streptococcus pharyngeal infection and need long-term 
antibiotic prophylaxis to prevent severe disease and 
RHD. Here we present a Case report about patient who 
has RF and RHD history since the age of 10 years old. 
This case is reported to show the management and 
prophylaxis treatment for recurrent RF that can be done 
next to prevent recurrence of RF in the future. Keyword : 
Recurrent Rheumatic Fever, Rheumatic Fever 
 
 
Introduction  
Rheumatic fever (RF) prevalence is quite high and 
more common in children and rarely in adults. RF 
is autoimmune disease resulted from Group-A 
Streptococcus upper respiratory tract infection. 
This Streptococcus is gram positive extracellular 
pathogen that usually infects pharynx.1 RF evokes 
general inflammation involving heart, joints, skin, 
and brain, either simultaneously or selectively. RF 
can usually cause rheumatic heart disease later in 
life.  
In the case of rheumatic heart disease (RHD), 
with heart valve damage, the proper management 
can be implemented, RHD be controlled.2 RF 
diagnostic criteria have changed from the 
beginning. Currently, World Health Organization 
(WHO) classifies RF diagnostic criteria into 
primary episode, recurrent episode, and rheumatic 
chorea with chronic valve lesion. RF is diagnosed 
based on Jones Criteria consisting major and minor 
criteria. Supporting evidence of Streptococcus 
infection becomes one of the diagnostic criteria 
used.3 Patients with RF episode history have a 
higher risk to experience recurrence following 
Group-A Streptococcus pharyngeal infection and 
need long-term antibiotic prophylaxis to prevent 
severe disease and RHD.4  
We hereby submit a case report about RF and 
RHD suffered by a patient since the age of 10 years 
old. He also has undergone routine treatment and has 
been declared cured since the age of 18 years old. He 
never experiences any symptoms for 2 years until 
finally at the age of 20, he experienced RF and 
pharyngitis symptoms caused by Group-A 
 
 
Streptococcus. Based on the diagnostic evaluation, 
it was considered as recurrent RF. After the 
treatment was done, his condition improved and he 
was allowed to go outpatient. This case was 
reported to show recurrent RF management and 
prophylaxis treatment can be done next to prevent 
recurrence of RF in the future. 
 
Case Illustration  
Twenty-year old male patient complaint about legs 
and arms pain which is felt getting worse 1 day prior 
to admission (PTA). These symptoms occurred when 
he was doing ordinary activities. There was no 
traumatic history before. These symptoms first 
appeared 2 weeks PTA, started with fever, cough, and 
rhinorrhea. Suddenly high fever occurred 
accompanied by sore throat and non-productive 
cough. He also felt lumps in several area of his body, 
such as plantar part of left foot, left edge of left foot, 
dorsal-part of right foot, upper left quadrant of 
abdomen, and near the left elbow. These lumps were 
painful, mobile, and felt a bit soft. He experienced 
limitation during movement because of these painful 
symptom. Two days PTA, due to fever symptoms, he 
was treated in a private hospital. There, 
echocardiography and ASTO examination were done, 
and he was referred to the Cipto Mangunkusumo 
hospital.  
Ten years on PTA, the patient had experienced 
the same symptoms accompanied by joints pain in 
the arms and legs. He also complained palpitations 
and fatigue. He was diagnosed with RF and RHD 
by paediatrician. He routinely went to the doctor 
and get Penicillin G benzathine injection until the 
age of 18 (for 8 years). He was also prescribed 
analgesic medication. Two-years PTA, general 
evaluation, including echocardiography, was 
carried out, and the results were good. He was 
declared cured of RHD and RF.  
For the past 2 years, he no longer went to doctor, 
all drugs have been stopped, and no symptoms have 
been appeared. He does his usual daily activities, 
including climbing mountains. He did not consume 
drugs or suffer from diseases such as diabetes, 
hypertension, kidney disease, asthma, and all kinds 
of allergic reactions. He is the first child of two 
siblings.  
Currently he is a student. He became a smoker and 
has a history of alcoholic beverages. He has stopped 
consuming alcohol for the last 4 months. He does not 
engage in promiscuity or taking drugs. His dietary 
habit was nutritious. He lived with his 
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parents and used national health insurance.  
Physical examination showed vital signs and body mass index 
within normal limits. General physical examination such as 
conjunctiva, pharynx, heart, lungs, abdomen, and examination of 
the extremities is normal. Capillary filling time  
< 2 seconds. On local physical examination, there are several 
lumps in several areas such as the left leg, right leg, left arm, 
right arm, and upper left abdominal quadrant. The lumps are 
soft, easy to move, warm, and painful when touched. The 
lumps are considered as erythema nodosum.  
Based on laboratory findings there are Hemoglobin 16,2 
g/dL, hematocrite 46%, leucocyte 20.300/µL, thrombocyte 
310.000/µL, electrolyte Na/K/Cl 141/3,8/105 mg/dL; PT/ APTT 
10,7” (10,4”) / 37,8” (30,6”) ; urea/creatinine17/1,0 mg/dL; LED 
68 mm AST/ALT10/5,5 /µL; MCV/MCH: 82/29. Urinary 
findings are within normal limits. Some antibiotics such as 
Cotrimoxazole, Tetracycline, Amoxicilin/ Clavulanic acid, 
Ceftriaxone, Meropenem, Levofloxacin, and Moxifloxacin-were 
found to be still sensitive to Klebsiella pneumonia from 
pharyngeal swabs. Gram staining examination found Gram 
negative bacteria, leucoyte 0-1, ephitelial cells  
0-1. Chest X-ray (figure 2.1), and electrocardiography (figure  
2.2) are normal. Echocardiographic examination results in 
2014 (figure 2.3) were obtained within normal limits, no valve 
abnormalities, global normokinetic wall movements, and no 
pleural effusion. Re-evaluation of echocardiographic 
examination found global normokinetic wall movement, TR 
trivial, good systolic LV and RV function (EF 71%, TAPSE  
26.3), good diastolic function, no vegetation (figure 2.4). His  
ASTO positively resulted 400 and reactive.  
Therefore, this patient’s assessments were multiple 
erythema nodosum, recurrent RF, acute tonsilopharyngitis. 
The management given were soft diet 1700 kcal/day, room air 
O2, IVFD Normal Saline 500mL/8 hours, Benzathine 
penicillin 1x1,2 M unit IM (in emergency department), 
Clindamycin 4x600mg (po), Sodium diclofenac 2x50mg (po), 
Methylprednisolone 3x8 mg (po), Lanzoprazole 1x30 mg 
(po).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Chest X-Ray (7th March 2018) 
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Figure 2.2. Electrocardiography (7th March 2018)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Echocardiography (2014) 
 
Indonesian Journal of Rheumatology 2019; Vol 11 No. 2 33 
Case Report  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4. Echocardiography (12nd March 2018)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5. Photo of patient (with patient’s permission) 
 
 
Definition 
Rheumatic fever (RF) is non-suppurative sequelae and 
inflammatory response to Streptococcus pyogenes (group A 
beta-hemolytic streptococcus [GABHS]) infection which 
commonly occurs 2-3 weeks after a throat infection, affecting 
mainly children and young adults.1 
 
Etiology 
Streptococci is a group of gram-positive bacteria that is 
morphologically characterized by coccus and its chains. 
Streptococcus pyogenes, which belongs to GABHS, has the 
ability to produce toxins capable of lysing the red blood cells. 
The cytoplasmic membrane is surrounded by a thick layer of 
peptidoglycan of which is surrounded by S layer consists of 
carbohydrates, proteins, and glycoproteins. There is also 
specific type of carbohydrates, rhamnose-N-acetyl-
glucosamine dimers with the ability to cross-react with the 
glycosides of heart valves.5  
The S layer also contains M proteins that have varying 
molecular structure. The GABHS has more than 130 serotypes 
of M proteins. M proteins play an important role in the 
pathogenesis of streptococcal infection, each of which can 
cause different clinical manifestation. Some M serotypes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6. Erythema nodosum (with patient’s permission)  
 
are associated with acute RF. M proteins may also escape from 
immune system by inhibiting the complement activation and 
phagocytosis. M-like proteins bind to Fc part from IgG and IgA 
molecules, thus exposing the immunoglobulin layer around the 
bacteria with Fab part facing outward. This mechanism can 
inhibit phagocytosis and immune recognition. The bacteria cell 
walls are surrounded by hyaluronic acid capsules. Since its 
molecular structure is very similar to human hyaluronic acid, it 
gives additional protection against human innate immunity. Some 
rheumatogenic M serotypes have thick capsules and produce 
mucus when grown on blood agar.5 Streptococci produces many 
extracellular 
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products, such as erythrogenic toxin, streptolysin O, 
streptolysin S, streptokinase, diphosphoridyne nucleotidase, 
and deoxyribonuclease. Streptolysin O may trigger antibody 
response, antistreptolysin O (ASO), which forms the basis of 
antibody testing. The antigenicity of which is inhibited by 
lipid layer of the skin that explains the least association 
between streptococcal infection of the skin and RF. 
Streptococci has many antigens similar with mammalian 
tissues and can cross-reacts with joints, heart (myocardium 
and heart valves), skin, kidneys, and brain.5 
 
Epidemiology 
The prevalence of RF is high especially in developing 
countries. The global incidence of acute RF is estimated at 
471,000 cases per year with incidence in children aged 5-15 
years between 10 to 374 cases per 100,000 in pacific region.6 
The peak incidence of acute RF is children aged 5-15 year.2,7 
Rheumatic heart disease (RHD) is the most common 
complication of RF. The number of deaths due to RHD is 
around 233,000 deaths per year. It is estimated that there are 
15 million people with RHD worldwide, affecting mainly 
children and young adults.1,8 Recurrent RF is associated with 
the increased frequency of carditis and other cardiac 
abnormalities. The incidence of recurrent RF is about 15– 
34%. The recurrence is high in people with the history of 
carditis as well as young age.8 Individual with family history 
of acute RF have five-fold greater risk of developing RF.7 
 
Pathogenesis 
RF is a consequence of Streptococcus pyogenes pharyngeal 
infection. The antigen mimicry of the organism and proteins 
from the human body can cause both humoral and cell-
mediated autoimmune reaction leading to RF. It takes about 3 
weeks after the S. pyogenes infection to induce a RF as well 
as causing inflammation of the brain, joints, skin, heart, and 
other organs.7 S. pyogenes contains M, T, and R proteins 
which are associated with the attachment of bacteria to the 
epithelial cells of the throat. M serotype proteins have the 
highest rheumatogenesity amongst the other serotypes. The 
class II HLA molecules, which contributes in antigen 
presentation of T-cell receptors) appears to be more associated 
with an increased risk of acute RF and RHD compared to class 
I HLA molecules, although there has not been any single or 
combination of HLA molecules which consistently associated 
with rheumatic disease susceptibility. The molecular 
mechanism of class II HLA molecules and its effect to the 
rheumatic disease susceptibility has not been fully 
understood.7  
The autoimmune reaction of RF occurs when the antibodies 
of GABHS react to human heart. After binding to antigen 
peptides, the HLA complex initiates an inappropriate T-cell 
activation. Molecular mimicry of M protein and other heart 
proteins (myosine, tropomyosine, creatine, laminine, and 
vimnetin) as well as T-cell cross-recognition of antigen have been 
identified as the underlying mechanism of RF.9 Mannose-binding 
lectin (MBL) is acute phase inflammatory protein that functions 
as soluble pathogen recognition receptor. MBL binds various type 
of sugars on the pathogen’s surface and has 
Case Report 
 
important role in innate immunity due to its ability to attack 
pathogen, enhance phagocytosis, and activate complement 
cascade through lectin pathway.10 Cytokines (IL-1, IL-6, TNF-
α) also have a role in acute RF.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Acute Rheumatic Fever Pathogenesis11  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. The immune cross-reaction response 
between GABHS and heart11 
 
Clinical Manifestation 
Acute RF is usually preceded by GABHS pharyngitis. All 
clinicians, especially in high-risk populations must thoroughly 
distinguish GABHS pharyngitis from other pathogens. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. GABHS acute tonsilopharyngitis12 
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Table 3.1. Clinical features and diagnosis of GABHS pharyngitis13  
 
Clinical features of suspected GABHS infection:  
• Abrupt sore throat  
• Odynophagia  
• Fever  
• Headache  
• Scarlet fever rash  
• Nausea, vomiting, and abdominal pain  
• Hyperemic tonsils and pharynx  
• Exudates on tonsils and pharynx  
• Soft palate petechiae (doughnut-like lesions)  
• Hyperemic and swollen uvula  
• Tender anterior nodules  
• 5-15-year old patient  
• previous exposure history   
Clinical features of viral infection:  
• Conjunctivitis  
• Coryza  
• Hoarseness  
• Cough  
• Diarrhea  
• Exanthema  
• Anathema  
 
Generally, major clinical features of acute RF first episode 
 
 
the criteria have tendency to overdiagnose and made further 
specific examination required, such as echocardiography. 
Hence in 2015 American Heart Association revised the 
criteria. The diagnosis acute rheumatic heart disease could be 
made if there are two major criteria or one major with two 
minors.14  
 
Table 3.2. Revised Jones Criteria (2015)   
First episode of acute rheumatic Recurrent RFL 
fever: - Two majors 
- Two majors - One major + two minors, or 3 
- One major + 2 minors minors 
 
Criteria 
Low-risk population Moderate and high-risk 
 population 
  
Major criteria: Major criteria: 
- Carditis (clinical and/or - Carditis (clinical and/or 
subclinical) subclinical) 
- Arthritis (polyarthritis only) - Arthritis (monoarthritis, 
- Chorea polyarthritis and/or 
- Erythema marginatum polyarthralgia) 
- Subcutaneous nodules - Chorea 
 - Erythema marginatum 
 - Subcutaneous nodules  
 
are carditis (50-70%) and arthritis (35-66%).14 Carditis 
(valvulitis), which is one of acute RF major criteria, can be 
clinically diagnosed by finding the murmur in auscultation 
indicating mitral regurgitation (systolic murmur) or aorta 
regurgitation (diastolic murmur). Mitral valves are the most 
common affected valve. Pericarditis and myocarditis may 
rarely also be affected. Classic RF-related arthritis symptom 
is migratory asymmetrical polyarthritis which commonly 
affected big joints.2 
 
Minor criteria:  
- Polyarthralgia  
- Fever (≥ 38,5oC)  
- Increased ESR ( ≥60 mm in the 
first hour) and/or CRP (≥3 mg/ 
dL or more than normal value) 
- Prolonged PR interval (unless 
carditis is major criterion) 
 
 
Minor criteria:  
- Monoarthralgia  
- Fever (≥ 38,5oC)  
- Increased ESR ( ≥60 mm 
in the first hour) and/or 
CRP (≥3 mg/dL or more 
than normal value) 
- Prolonged PR interval (unless 
carditis is major criterion) 
 
The other symptoms of RF are sydenham chorea (10-30%) 
which commonly affects women, subcutaneous nodules (0-10%), 
and erythema marginatum (<6%).14 Subcutaneous nodules and 
erythema marginatum are very rare findings but very specific in 
diagnosing acute RF.13 Erythema marginatum is a hyperemic skin 
lesion with pale center, round (serpiginous) margins. A non-
pruritic or painful rashes usually occur on the body trunk or 
proximal extremities. Subcutaneous nodules are non-painful 
nodules commonly found on the extensor joints, especially knee, 
elbow, wrist, as well as thoracal and lumbar vertebrae joints. 
Syndenham chorea is involuntary and non-stereotypical 
movements of the trunk and extremities. Other symptoms are 
speech disturbances, frequent dropping of objects, impaired 
writing ability, and emotional disturbances.2,14 Syndenham 
chorea is a self-limiting symptom which usually takes few weeks 
to 6 months to heal while some may take 2-3 years. Mild to 
moderate chorea does not need specific therapy. Chorea can be 
triggered by stress and overstimulation.15 
 
Diagnosis  
Diagnostic Criteria 
Jones criteria is commonly used to diagnose acute RF. In high-
risk population, these criteria are commonly used, while in the 
low-risk population, these criteria cannot be used. Moreover, 
 
Evidence of preceding GABHS infection (positive throat 
culture, positive rapid antigen detection test (RADT), 
increased of anti-streptococcal antibodies titer).  
 
Table 3.3. The comparison of echocardiography 
involvement in diagnosis guidelines :   
  Perform  Use echo 
  echo in all- Perform to confirm 
Year Guidelines 
confirmed echo in all carditis as 
cases of ARF suspected major criterion   
  without clinical cases of ARF? in absence of 
  carditis?  murmur? 
     
1992 Jones Criteria No No No 
2000 Jones Criteria No No No 
 Workshop    
2001 WHO guidelines Yes No No 
2008 Indian working Yes No No 
 group    
2008 New Zealand Yes Yes Yes 
 guidelines    
2012 Australia Yes Yes Yes 
 guidelines    
2015 Jones Criteria Yes Yes Yes 
 2015    
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Diagnostic tools  
Echocardiography and Doppler 
In an era where auscultation ability tend to be decreasing and 
the availability of more advanced cardiac ultrasound is 
increasing, echocardiography combined with Doppler should 
be used as a diagnostic tool for all cases of suspected acute 
rheumatic fever. 
 
Table 3.4. Doppler assessment in rheumatic valvulitis  
 
Pathological mitral regurgitation (all 4 criteria met)  
- Seen in at least 2 views  
- Jet length ≥ 2 cm in at least 1 view  
- Peak velocity > 3 m/s  
- Pansystolic jet in at least 1 envelope 
Pathological aortic regurgitation (all 4 criteria met) 
 
- Seen in at least 2 views  
- Jet length ≥ 1 cm in at least 1 view  
- Peak velocity > 3 m/s  
- Pan diastolic jet in at least 1 envelope  
 
Loading conditions should be accounted for at time of 
echocardiogra-phy/doppler assessment .  
 
Table 3.5. Echocardiogram in rheumatic valvulitis  
 
Acute mitral valve changes  
- Annular dilation  
- Chordal elongation  
- Chordal rupture resulting in flail leaflet with severe 
mitral regurgi-tation  
- Anterior (or less commonly posterior)leaflet tip prolapse  
- Beading/nodularity of leaflet tips  
Chronic mitral valve changes: not seen in acute carditis  
- Leaflet thickening  
- Chordal thickening and fusion  
- Restricted leaflet motion  
- Calcification  
Aortic valve changes in either acute or chronic carditis  
- Irregular or focal leaflet thickening  
- Coaptation defect  
- Restricted leaflet motion  
- Leaflet prolapse   
On occasion, particularly early in the course of acute rheumatic 
fever, mitral or valve morphology may be normal on 
echocardiogram while Doppler shows regurgitation. These 
findings can also seen in chronic rheumatic heart disease.  
 
Laboratory examination 
Elevated erythrocyte sedimentation rate (ESR) and/or C-reative 
protein (CRP) is one of rheumatic fever criterion. Leukocytosis 
and mild anemia are often found but not specific for ARF. The 
diagnosis of preceding streptococcal infection could be 
established if one of the following criteria is found:  
• Increased anti-streptolysin O (ASTO) titre or other 
streptococcal antibodies (anti-DNASE B)  
• A positive throat culture for group A β-hemolytic 
streptococcus  
• A positive rapid group A streptococcal carbohydrate 
antigen test in a child whose clinical presentation suggests 
a high probability of streptococcal pharyngitis. 
Case Report 
 
Usually, ASTO is checked first and if the result is negative 
then anti-DNASE B test can be done. ASTO titer will increase 
after one week of infection, and reach its peak level on the 
third week to sixth week post infection. The increase in titer 
of ASTO and anti-DNASE B may persist for several months 
after GABHS infection. 
 
Treatment 
First-line treatment of RF is to eradicate the agent of infection, 
which is GABHS. The preferred choice of antibiotics is 
penicillin G benzathine 1,200,000 IU intramuscularly (IM) for 
children weighed >20 kg or 600,000 IU for children weighed 
<20 kg. Other alternatives include:13  
• Patients which cannot receive intramuscular injection due 
to hemorrhagic disease can be given oral penicillin V (50 
mg/kg/day, 4 times/day) or amoxicillin (50 mg/kg/day, 3 
times/day) for 10 days 
• Patients allergic to penicillin and its derivatives can be 
given erythromycin (40 mg/kg/day, 4 times/day for 10  
days) or azithromycin (20 mg/kg/day, once daily for 3 
days). Tetracycline (high risk of resistance), sulfonamide 
(cannot eradicate the agents), and chloramphenicol (high 
toxicity) should not be used.  
Other clinical manifestations can also be treated:  
• Arthritis: nonsteroidal anti-inflammatory drugs (NSAID)  
for 7-10 days, preferred via oral route:16  
o Acetylsalicylic acid (80-100 mg/kg/day) 
o Naproxen (10-20 mg/kg/day) 
o Ibuprofen (30 mg/kg/day) o 
Ketoprofen (1.5 mg/kg/day)  
• Carditis: prednison (1-2 mg/kg/day), preferred via oral route, 
maximum dosage 60 mg/day. The full dosage can be divided 
into 2 or 3 dosage/day for 15 days and then tappered 20-25% 
of the dosage for every following week.13  
• Chorea: Mild to moderate chorea does not need specific 
therapy besides enough rest and avoiding stressors.15  
Severe chorea can be treated with oral haloperidol (1 mg/ 
day divided to 2 times/day), the dosage can be titrated 
0,5 mg every 3 days until the desired effects is reached or 
maximum dosage 5 mg/day. The treatment is given for 3 
months.17 Extrapyramidal symptoms commonly occur 
when the dosage is close to maximum dosage.  
The alternative is valproate acid (30 mg/kg/day, starting 
from 10 mg/kg/day titrated 10 mg/kg/week).18 The acute 
RF guidelines by Australia and New Zealand prefer the 
valproate acid and carbamazepine as the first-line therapy 
for chorea due to its fewer side effects.15 
 
Complication 
Mild to moderate carditis, the valve regurgitation can be stable 
and get better 12 months after diagnosis. Individuals with 
severe carditis in the first or recurrent episode is at higher risk 
of developing chronic RHD, associated with higher risk of 
heart failure, infective endocarditis, pregnancy complication, 
stroke, arrhythmia, and premature deaths.2 
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Recurrent rheumatic fever 
The diagnosis of recurrent rheumatic fever can be established 
in individuals with history of acute RF or have been diagnosed 
with RHD and documented GABHS infection (2 major 
criteria or 1 major and 2 minor criteria or 3 minor criteria, or 
2 minor WHO criteria).14 Risk factors of higher risk of RF 
recurrence:8,19  
• Young age (<23 years old)  
• Inadequate secondary prophylaxis  
• History of heart failure 
 
Prevention 
The strategy of RF prevention divided into primary and 
secondary prevention, which are very important to reduce the 
incidence of RHD. 
 
Primary prevention 
The ideal prophylaxis should be able to prevent acute RF 
episodes, especially when given immediately after the 
diagnosis of pharyngitis. Primary prophylaxis aims to 
eradicate GABHS infection through pharyngitis screening and 
oral or IM antibiotics. All patients suspected of GABHS 
pharyngitis (Table 1) is recommended to have throat swab 
culture or rapid antigen detection test (RADT). 
Recommended antibiotics for primary prevention are the same 
antibiotics given for the treatment of RF.13 
 
Table 3.6. Primary prevention of RF (streptococcal 
tonsilopharyngitis)13 the criterion standard of which is the 
throat culture. Penicillin (either oral penicillin V or 
injectable benzathine penicillin   
Therapy Dosage Roue Duration 
    
Penicilin:    
    
Penicillin V Children (BW ≤27 kg): 250 Oral 10 days 
(phenoxymethyl mg, 2-3 times/day   
penicillin) Children (BB >27 kg), ado-   
 lescence, dan adults: 500 mg,   
 2-3 times/day   
Amoxicillin 50 mg/kg/day (max. 1 g) Oral 10 days 
Benzathine 600,000 IU (BW ≤27 kg), or IM Single dose 
penicillin G 1,200,000 IU (BW >27 kg)   
   
Alternatives when allergic to penicillin:   
    
Cephalosporin Varied Oral 10 days 
narrow spectrum    
(cephalexin,    
cefadroxil)    
Clindamycin 20 mg/kg/day divided into 3 Oral 10 days 
 dosages (max. 1.8 g/day)   
Azitromycin 12 mg/kg/day, once daily Oral 5 days 
 (max. 500 mg)   
Clarithromycin 15 mg/kg/day divided into 2 Oral 10 days 
 dosages   
 
Sulfonamide, tetracycline, and fluoroquinolone are not recommended.  
 
3.10.2. Secondary prevention 
 
 
Secondary prevention aims to prevent the recurrence or 
chronic RF. Recurrent RF can also occur even in patients who 
have undergone optimal therapy thus the secondary prevention 
is continuously given to prevent the recurrence.13  
 
Table 3.8. Secondary prevention of RF (prevention of 
recurrence)13 the criterion standard of which is the throat culture. 
Penicillin (either oral penicillin V or injectable benzathine penicillin 
 
Therapy Dosage Route 
Benzatihine penicillin G  600,000 IU (BW ≤27 kg), IM 
 1,200,000 IU (BW >27 kg) every  
 4 weeks  
Penicillin V 2x250 mg Oral 
Sulfadiazine 0.5 g/day (BW ≤27 kg), 1 g/day Oral 
 (BW >27 kg)  
Alternatives when Varied Oral 
allergic to penicillin or   
sulfadiazine:   
Macrolide or azalide   
 
Table 3.8. Duration of secondary prophylaxis for RF13 the 
criterion standard of which is the throat culture. Penicillin 
(either oral penicillin V or injectable benzathine penicillin   
Category Duration after last episode 
  
RF with carditis and residual 10 years or until 40 years 
heart disease (persistent valve old, some cases need lifelong 
disorder) treatment 
  
RF with carditis without residual 10 years or until 21 years old 
heart disease (no valve disorder)  
  
RF without carditis 5 years or until 21 years old 
  
 
Patients’ compliance of taking secondary prophylaxis is very 
important. Doctors should provide enough information to the 
patients or parents about the benefits and importance of 
adherence in order to achieve treatment success, ensure 
patients about the effectivity of the treatment, using the control 
cards, optimize support from the family and environment to 
help the patients take medication regularly. The patients need 
supervisor to ensure the patients take the medicine regularly 
until the schedule is finished.19 
 
Discussion  
Based on evaluation, it was obtained several assessments such 
as recurrent RF, multiple erythema nodosum, acute 
tonsilopharyngitis. 
 
Recurrent RF  
The patient is 20-year old male. His chief complaint was 
painful lumps 2 weeks PTA. This symptom is immunologic 
phenomenon that is called Erythema Nodosum. This symptom 
was preceded by acute pharyngitis episode, accompanied by 
childhood RF history. Erythema nodosum is not cardinal 
symptom of RF. Distinguished from rheumatic nodule, 
erythema nodosum characteristically has pain on palpation. 
Erythema nodosum appearance does not necessarily leads to 
recurrent RF disease until the other causes related to this lump 
were excluded. 
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In this case, recurrent RF diagnosis was made by 
the elevated ASTO titer showing evidence of Group-A 
Streptococcus’s infection. The RF minor criteria in this 
case were fever, polyarthritis, elevated ESR, and 
previous RF history. Although there is no evidence of 
carditis due to normal result of electrocardiography and 
echocardiography, based on Jones criteria, this patient 
can be diagnosed as recurrent RF based on the presence 
of polyarthritis as the major criteria and additionally 
presence of fever, elevated ESR, elevated ASTO titer 
as the minor criteria. This patient has been diagnosed 
RHD and had routinely gotten treatment for 8 years. 
The risk factor of recurrent RF is inadequate secondary 
prophylaxis. Secondary treatment for carditis related-
RF must be given for 10 years. The other recurrence 
risk factor is RHD as RF complication. Patients who 
have RHD tend to have a higher recurrence risk 
compared with the others without RHD history. This 
patient has also been gotten an intramuscular injection 
of benzathine penicillin with dose 1x1.2 M unit. This 
treatment should be continued as the secondary 
prophylaxis for 5 years.  
Clindamycin was used to eradicate Group-A 
Streptococcus. Clindamycin is effective for Group-
A Streptococcus, and this antibiotic can be given 
orally. NSAID was given to relieve erythema 
nodosum-related pain symptom. Erythema 
nodosum is a lump with characteristically pain on 
palpation symptom. It can grow in any part of body, 
but some were related with systemic disorder. 
Although erythema nodosum was not included in 
RF diagnostic criteria, its prevalence was fairly 
high. 
 
Multiple Erythema Nodosum 
The pain at both leg and arm were felt since 2 weeks 
PTA. There are multiple lumps in hand, foot, and 
abdominal. These lumps were characteristically pain 
on palpation, and slightly soft. There was RHD history. 
We considered it as erythema nodosum because its 
characteristic was different, either from erythema 
marginatum or subcutaneous nodule which do not have 
pain on palpation symptom. We excluded other 
systemic diseases by performing several examination 
such as chest X-ray to exclude Tuberculosis, and 
sputum examination cannot carried out from patients 
and we don’t do the biopsy because at this time patient 
have a good respond for our treatment. Group-A 
Streptococcus infection evident showed that this 
pathogen can cause erythema nodosum. Based on these 
findings, we considered there was relation between 
erythema nodosum, Group-A Streptococcus infection, 
and RF. 
 
Acute Tonsillopharyngitis 
The patient experienced fever, sore throat, cough, and 
rhinorrhea. Physical examination showed hyperemic 
pharynx. Laboratory findings show elevated leucocyte 
count 20.300/µL and from pharyngeal swab we found 
Klebsiella pneumonia that sensitive to cotrimoxazole, 
tetrasiklin, amoxicillin/ clavulanic acid , ceftriaxone, 
meropenem, levofloxacin and moxifloxacin. Gram 
staining examination showed negative-gram bacteria, 
with slightly increase the number of leucocyte, and 
epithelial cells. The treatment for this acute 
tonsillopharyngitis was Clindamycin 4x600mg orally. 
 
 
Conclusion 
Rheumatic fever is a rare case, especially recurrent 
case in adulthood. Besides immediate treatment, the 
patients also needs prophylactic therapy to prevent 
disease recurrence. With the good history taking, 
physical examination, and comprehensive 
investigation, diagnosing and treating RF and RHD 
can be done. 
 
References 
1. Seckeler MD, Hoke TR. The worldwide epidemiology of acute 
rheumatic fever and rheumatic heart disease. Clin Epidemiol. 
2011;3(1):67-84. 
2. Webb RH, Grant C, Harnden A. Acute rheumatic 
fever. Bmj. 2015;3443(July):h3443. 
3. Zühlke LJ, Beaton A, Engel ME, et al. Group A Streptococcus, 
Acute Rheumatic Fever and Rheumatic Heart Disease: 
Epidemiology and Clinical Considerations. Curr Treat Options 
Cardiovasc Med. 2017;19(2). 
4. WHO. Rheumatic fever and rheumatic heart disease. 
World Health Organ Tech Rep Ser. 
2004;923(November 2001):1-122.  
5. Mody GM, Mayosi BM. Acute Rheumatic Fever. 
Vol 7. Fifth Edit. Elsevier Inc.; 2012. 
6. Zühlke LJ, Steer AC. Estimates of the global 
burden of rheumatic heart disease. Glob Heart. 
2013;8(3):189-95. 
7. Marijon E, Mirabel M, Celermajer DS, Jouven X. 
Rheumatic heart disease. Lancet. 
2012;379(9819):953-64.  
8. Camara EJN, Santos JM Dos, Alves-Silva LS, 
Latado AL. Rheumatic fever recurrence: Risk 
factors and clinical characteristics. Clin Trials 
Regul Sci Cardiol. 2016;19:5-8.  
9. Fae KC, Oshiro SE, Toubert A, Charron D, Kalil J, 
Guilherme L. How an autoimmune reaction triggered by 
molecular mimicry between streptococcal M protein and 
cardiac tissue proteins leads to heart lesions in rheumatic 
heart disease. J Autoimmun. 2005;24:101–9. 
10. Jack DL, Klein NJ, Turner MW. Mannose-binding 
lectin: targeting the microbial world for 
complement attack and opsonophagocytosis. 
Immunol Rev. 2001;180:86–99.  
11. Carapetis J, Beaton A, Karthikeyan G, Mayosi 
BM, Sable C, Steer A. Acute rheumatic fever and 
rheumatic heart disease. Nat Rev Dis Prim. 
2016;2:15085.  
12. Smith MT, Zurynski Y, Lester-Smith D, Elliott E, 
Carapetis J. Rheumatic fever Identification, 
management and secondary prevention. Aust Fam 
Physician. 2012;41(1-2):31-5.  
13. Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of 
Rheumatic Fever and Diagnosis and Treatment of Acute 
Streptococcal Pharyngitis: A Scientific Statement From the 
American Heart Association Rheumatic Fever, Endocarditis, 
and Kawasaki Disease Committee of the Council on 
Cardiovascular Disease. Circulation. 2009;119(11):1541-51. 
14. Gewitz MH, Baltimore RS, Tani LY, et al. Revision of the 
Jones criteria for the diagnosis of acute rheumatic fever in 
the era of Doppler echocardiography a scientific statement 
from the American heart association. Circulation. 
2015;131(20):1806-1818. 
15. The National Heart Foundation of New Zealand. 
New Zealand Guidelines for Rheumatic Fever 1. 
Diagnosis, Management and Secondary Prevention 
of Acute Rheumatic Fever and Rheumatic Heart 
Disease: 2014 Update. 2014:1-100.  
16. Chakravarty SD, Zabriskie JB, Gibofsky A. Acute 
rheumatic fever and streptococci: the quintessential 
pathogenic trigger of autoimmunity. Clin Rheumatol. 
2014;33:893–901.  
17. Tumas V, Caldas CT, Santos AC, Nobre A FR. 
Sydenham’s chorea: clinical observations from a 
Brazilian movement disorder clinic. Park Relat 
Disord. 2007;13:276–83.  
18. Genel F, Arslanoglu S, Uran N SB. Sydenham’s 
chorea: clinical findings and comparison of the 
efficacies of sodium valproate and carbamazepine 
regimens. Brain Dev. 2002;24:73–6.  
19. Rahmawaty N, Iskandar B, Albar H, Daud D. 
Faktor Risiko Serangan Berulang Demam 
Rematik/Penyakit Jantung Rematik. Sari Pediatr. 
2012;14(3):179-84. 
 
